The REAL-KET research team is a multidisciplinary collaboration dedicated to advancing knowledge on ketamine treatment for depression in routine clinical practice. REAL-KET is a national observational study led by Lund University and Region Skåne in collaboration with universities, hospitals, and specialized psychiatric clinics across Sweden.
Bringing together expertise in psychiatry, clinical research, neuroscience, biomarker analysis, and data science, the team works to generate high-quality real-world evidence on the effectiveness, safety, and long-term outcomes of ketamine treatment. Through close collaboration across participating centers, the study aims to improve patient care and contribute to the future development of evidence-based treatment strategies for depression.
Pouya Movahed Rad, MD, PhD
Principal Investigator
Consultant Psychiatrist and Associate Professor at Lund University Dr. Movahed Rad brings deep clinical and research experience in psychiatry, with a special focus on severe depression. He has led clinical trials involving treatments such as electroconvulsive therapy (ECT), ketamine, and now psychedelic-assisted interventions.
Elin Thörnblom, MD, PhD
National Coordinating Investigator & Scientific Lead
Responsible for the national coordination of the REAL-KET study, including the initiation of new study sites, implementation of study protocols, training of local research teams, and quality assurance of data collection.
Merve Cingi Yirün, MD
Research Fellow and PhD Candidate
Responsible for the national coordination of biomarker projects, data management and scientific analyses within the REAL-KET study, while simultaneously conducting her PhD research as part of the study.
